Logo image of PCN

PIMCO CORPORATE & INCOME STR (PCN) Stock Price, Quote, News and Overview

NYSE:PCN - New York Stock Exchange, Inc. - US72200U1007 - Currency: USD

13.75  -0.01 (-0.07%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to PCN. PCN was compared to 0 industry peers in the Unkown industry. PCN may be in some trouble as it scores bad on both profitability and health. PCN does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year PCN was profitable.
Of the past 5 years PCN 4 years were profitable.
Of the past 5 years PCN 4 years had a positive operating cash flow.
PCN Yearly Net Income VS EBIT VS OCF VS FCFPCN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

1.2 Ratios

The 3 year average ROIC (5.35%) for PCN is below the current ROIC(5.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.35%
ROE 6.52%
ROIC 5.85%
ROA(3y)4.24%
ROA(5y)4.86%
ROE(3y)6.8%
ROE(5y)6.95%
ROIC(3y)5.35%
ROIC(5y)5.2%
PCN Yearly ROA, ROE, ROICPCN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15

1.3 Margins

PCN's Profit Margin has declined in the last couple of years.
PCN's Operating Margin has been stable in the last couple of years.
PCN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 81.26%
PM (TTM) 59.34%
GM 81.57%
OM growth 3Y-1.05%
OM growth 5Y-1.27%
PM growth 3Y-13.95%
PM growth 5Y-22.84%
GM growth 3Y-1.03%
GM growth 5Y-1.27%
PCN Yearly Profit, Operating, Gross MarginsPCN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 150 200

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, PCN has more shares outstanding
The number of shares outstanding for PCN has been increased compared to 5 years ago.
Compared to 1 year ago, PCN has an improved debt to assets ratio.
PCN Yearly Shares OutstandingPCN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
PCN Yearly Total Debt VS Total AssetsPCN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 3.04 indicates that PCN is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.20 indicates that PCN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Altman-Z 3.04
ROIC/WACCN/A
WACCN/A
PCN Yearly LT Debt VS Equity VS FCFPCN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

2.3 Liquidity

PCN has a Current Ratio of 0.16. This is a bad value and indicates that PCN is not financially healthy enough and could expect problems in meeting its short term obligations.
PCN has a Quick Ratio of 0.16. This is a bad value and indicates that PCN is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.16
Quick Ratio 0.16
PCN Yearly Current Assets VS Current LiabilitesPCN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for PCN have decreased strongly by -71.68% in the last year.
The earnings per share for PCN have been decreasing by -21.77% on average. This is quite bad
PCN shows a strong growth in Revenue. In the last year, the Revenue has grown by 20.15%.
The Revenue has been growing slightly by 6.29% on average over the past years.
EPS 1Y (TTM)-71.68%
EPS 3Y-15.3%
EPS 5Y-21.77%
EPS Q2Q%141.03%
Revenue 1Y (TTM)20.15%
Revenue growth 3Y6.09%
Revenue growth 5Y6.29%
Sales Q2Q%-3.29%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PCN Yearly Revenue VS EstimatesPCN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
PCN Yearly EPS VS EstimatesPCN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 16.77, the valuation of PCN can be described as correct.
When comparing the Price/Earnings ratio of PCN to the average of the S&P500 Index (29.63), we can say PCN is valued slightly cheaper.
Industry RankSector Rank
PE 16.77
Fwd PE N/A
PCN Price Earnings VS Forward Price EarningsPCN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PCN Per share dataPCN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

PCN has a Yearly Dividend Yield of 9.00%, which is a nice return.
PCN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 9%

5.2 History

The dividend of PCN has a limited annual growth rate of 0.99%.
PCN has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)0.99%
Div Incr Years0
Div Non Decr Years0
PCN Yearly Dividends per sharePCN Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

The earnings of PCN are negative and hence is the payout ratio. PCN will probably not be able to sustain this dividend level.
DP-82.53%
EPS Next 2YN/A
EPS Next 3YN/A
PCN Yearly Income VS Free CF VS DividendPCN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M -200M

More info and screens

PIMCO CORPORATE & INCOME STR

NYSE:PCN (2/21/2025, 8:04:00 PM)

13.75

-0.01 (-0.07%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-29 2024-08-29
Earnings (Next)03-03 2025-03-03
Inst Owners18.46%
Inst Owner Change5.06%
Ins OwnersN/A
Ins Owner Change0%
Market Cap725.17M
Analysts0
Price TargetN/A
Short Float %0.2%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield 9%
Yearly Dividend1.34
Dividend Growth(5Y)0.99%
DP-82.53%
Div Incr Years0
Div Non Decr Years0
Ex-Date02-13 2025-02-13 (0.1125)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 16.77
Fwd PE N/A
P/S 10.59
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 1.16
EV/EBITDA N/A
EPS(TTM)0.82
EY5.96%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.3
BVpS11.82
TBVpS11.82
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.35%
ROE 6.52%
ROCE 8.83%
ROIC 5.85%
ROICexc 5.86%
ROICexgc 6.02%
OM 81.26%
PM (TTM) 59.34%
GM 81.57%
FCFM N/A
ROA(3y)4.24%
ROA(5y)4.86%
ROE(3y)6.8%
ROE(5y)6.95%
ROIC(3y)5.35%
ROIC(5y)5.2%
ROICexc(3y)5.35%
ROICexc(5y)5.2%
ROICexgc(3y)5.49%
ROICexgc(5y)5.33%
ROCE(3y)9.05%
ROCE(5y)8.43%
ROICexcg growth 3Y10.31%
ROICexcg growth 5Y6.81%
ROICexc growth 3Y10%
ROICexc growth 5Y6.5%
OM growth 3Y-1.05%
OM growth 5Y-1.27%
PM growth 3Y-13.95%
PM growth 5Y-22.84%
GM growth 3Y-1.03%
GM growth 5Y-1.27%
F-ScoreN/A
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.16
Quick Ratio 0.16
Altman-Z 3.04
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.68%
EPS 3Y-15.3%
EPS 5Y-21.77%
EPS Q2Q%141.03%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)20.15%
Revenue growth 3Y6.09%
Revenue growth 5Y6.29%
Sales Q2Q%-3.29%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y10.24%
EBIT growth 3Y4.98%
EBIT growth 5Y4.95%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y176.09%
FCF growth 3Y387.38%
FCF growth 5Y16.51%
OCF growth 1Y176.09%
OCF growth 3Y387.38%
OCF growth 5Y16.51%